| HGHYX | THISX | HGHYX / THISX | |
| Total Expense Ratio | 1.05 | 0.68 | 154% |
| Annual Report Gross Expense Ratio | 1.05 | 0.68 | 154% |
| Fund Existence | 26 years | 10 years | - |
| Gain YTD | 4.311 | 6.820 | 63% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 500000 | 50% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 776M | 11.9B | 7% |
| Annual Yield % from dividends | 0.00 | 0.27 | - |
| Returns for 1 year | 23.15 | 14.57 | 159% |
| Returns for 3 years | 14.54 | -1.31 | -1,111% |
| Returns for 5 years | -5.36 | -18.73 | 29% |
| Returns for 10 years | 33.78 | 36.53 | 92% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTCX | 34.79 | N/A | N/A |
| Fidelity Advisor Biotechnology C | |||
| MRIEX | 13.89 | N/A | N/A |
| Meridian Hedged Equity Investor | |||
| FLUEX | 30.02 | N/A | N/A |
| Fidelity Advisor Stk Selec Lg Cp Val C | |||
| ERSMX | 28.29 | N/A | N/A |
| Eaton Vance Atlanta Capital SMID-Cap R | |||
| WBCIX | 18.53 | -0.09 | -0.48% |
| William Blair Small-Mid Cap Core I | |||